CompletedEUCTR 2010-019635-36

A Single Centre, Open-Label, Randomised Multi-Dose Study to Assess Changes in the Brain Metabolism of Juvenile ADHD Patients After Thirteen Weeks of Daily Intake of 4 g Superba Krill Oil or 4 g ome...

This historical record does not confirm current site availability.

Historical research recordIceland

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Iceland
Study phase: Phase 2

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: Not clearly listed
Sponsor: Aker BioMarine Antarctic AS
Sponsor type: Unknown or unclear
Study type: Biological
Intervention type: BIOLOGICAL
Study phase: Phase 2
Locations: Iceland
Age range: Not clearly listed
Official registry ID: EUCTR 2010-019635-36
Official title: Show the full official title
A Single Centre, Open-Label, Randomised Multi-Dose Study to Assess Changes in the Brain Metabolism of Juvenile ADHD Patients After Thirteen Weeks of Daily Intake of 4 g Superba Krill Oil or 4 g ome...

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Iceland

Registry details

Historical country statuses

Iceland — Completed

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Aker BioMarine Antarctic AS.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me